AQST - Aquestive Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - AQST (1398733)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
7 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-03-15
AQSTSchobel Alexander MarkChief Innovation, Tech OfficerS - Sale$6.00-50,000984,476-5%-$300,000
2024-03-08
AQSTSchobel Alexander MarkChief Innovation, Tech OfficerS - Sale$5.19-25,0001,034,476-2%-$129,685
2022-06-14
AQSTBoyd Peter E.SVP-Bus. Process, Info. Tech.P - Purchase$0.81+5,00059,532+9%+$4,050
D
2022-06-08
AQSTBarber DanielCEOP - Purchase$0.96+91,743193,702+90%+$88,073
D
2022-06-08
AQSTSchobel Alexander MarkChief Innovation, Tech OfficerP - Purchase$0.96+45,871882,871+5%+$44,036
D
2022-06-08
AQSTBoyd Peter E.SVP-Bus. Process, Info. Tech.P - Purchase$0.96+2,29354,532+4%+$2,201
D
2022-06-08
AQSTBraender Lori JGCP - Purchase$0.96+13,76138,761+55%+$13,211

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top